UnknownNot Applicable

Anesthesia Endoscope Mask is Applied to Sedation Upper Gastrointestinal Endoscopic Diagnosis and Treatment

China1,208 participantsStarted 2023-10-18

Plain-language summary

To investigate the efficacy and safety of new-type mask compared with nasal tube oxygen delivery in patients undergoing sedation of upper gastrointestinal endoscopy

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 18 years;
✓. Upcoming upper gastrointestinal sedation procedure;
✓. Classification under the American Association of Anesthesiologists (ASA) status I-III;
✓. Baseline oxygen saturation (SpO2) ≥95% in ambient air conditions.

Exclusion criteria

✕. Individuals with previously documented difficulties in mask ventilation (DMV);
✕. Patients predisposed to aspiration risks or episodes of vomiting;
✕. Facial or jaw injuries or congenital abnormalities that render conventional face mask application infeasible;
✕. An inability or unwillingness to utilize the novel disposable anesthesia face mask.

What they're measuring

Incidence of hypoxemia

Timeframe: From the start of drug administration by the researcher to the completely withdraw from the endoscopy by the end of the examination.

Trial details

NCT IDNCT06085859

SponsorSichuan Provincial People's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-01

View on ClinicalTrials.gov More Hypoxemia trials